ID

29233

Beschrijving

Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00807092

Link

https://clinicaltrials.gov/show/NCT00807092

Trefwoorden

Versies (1)
  1. 10-03-18 10-03-18 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

10 maart 2018

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Diabetes NCT00807092

Engels

Eligibility Diabetes NCT00807092

1 Formulieren  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00807092
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes diagnosed for at least 6 months
Beschrijving

Non-Insulin-Dependent Diabetes Mellitus Disease length

Datatype

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0872146
insulin-naive (less than or equal to 1 week of daily use of insulin therapy)
Beschrijving

Insulin naive

Datatype

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C0919936
treatment with metformin as monotherapy or in combination therapy with other oad(s) for at least 3 months prior to this trial
Beschrijving

Metformin | Combined Modality Therapy | Antidiabetics Oral

Datatype

boolean

Alias
UMLS CUI [1]
C0025598
UMLS CUI [2]
C0009429
UMLS CUI [3,1]
C0935929
UMLS CUI [3,2]
C1527415
currently on metformin greater than or equal to 1000 mg/day for at least 2 weeks
Beschrijving

Metformin U/day

Datatype

boolean

Alias
UMLS CUI [1,1]
C0025598
UMLS CUI [1,2]
C0456683
currently at least one of other oad(s) reaching at least one-half of the recommended maximum dose for at least 2 weeks
Beschrijving

Antidiabetics Oral Quantity

Datatype

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C1265611
glycosylated haemoglobin (hba1c) between 7.5-11.0%
Beschrijving

Glucohemoglobin measurement

Datatype

boolean

Alias
UMLS CUI [1]
C0202054
body mass index (bmi) between 18.5 - 35.0 kg/m^2
Beschrijving

Body mass index

Datatype

boolean

Alias
UMLS CUI [1]
C1305855
be able and willing to perform continuous glucose monitoring system (cgms ) and self-monitored blood glucose (smbg)
Beschrijving

Glucose monitoring system Continuous | Blood Glucose Self-Monitoring

Datatype

boolean

Alias
UMLS CUI [1,1]
C3873850
UMLS CUI [1,2]
C0549178
UMLS CUI [2]
C0005803
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
known or suspected allergy to trial product(s) or related products
Beschrijving

Hypersensitivity Investigational New Drugs | Hypersensitivity Suspected Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Related | Hypersensitivity Suspected Pharmaceutical Preparations Related

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0750491
UMLS CUI [2,3]
C0013230
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0013227
UMLS CUI [3,3]
C0439849
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0750491
UMLS CUI [4,3]
C0013227
UMLS CUI [4,4]
C0439849
any contraindication of metformin
Beschrijving

Medical contraindication Metformin

Datatype

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0025598
receipt of investigational drug within the last 3 months prior to this trial
Beschrijving

Investigational New Drugs

Datatype

boolean

Alias
UMLS CUI [1]
C0013230
any history of chronic insulin therapy (more than 1 week of daily use)
Beschrijving

Insulin regime chronic

Datatype

boolean

Alias
UMLS CUI [1,1]
C0557978
UMLS CUI [1,2]
C0205191
systemically treated with thiazolidinediones (tzds) for more than one month within 6 months prior to this trial
Beschrijving

Systemic therapy Thiazolidinediones

Datatype

boolean

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C1257987
pregnancy, nursing mother, or unwillingness to use adequate contraception
Beschrijving

Pregnancy | Breast Feeding | Contraceptive methods Unwilling

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C0700589
UMLS CUI [3,2]
C0558080
Terug naar het begin van de pagina

Similar models

Eligibility Diabetes NCT00807092

1 Formulieren
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00807092
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Non-Insulin-Dependent Diabetes Mellitus Disease length
Item
type 2 diabetes diagnosed for at least 6 months
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Insulin naive
Item
insulin-naive (less than or equal to 1 week of daily use of insulin therapy)
boolean
C0021641 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
Metformin | Combined Modality Therapy | Antidiabetics Oral
Item
treatment with metformin as monotherapy or in combination therapy with other oad(s) for at least 3 months prior to this trial
boolean
C0025598 (UMLS CUI [1])
C0009429 (UMLS CUI [2])
C0935929 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
Metformin U/day
Item
currently on metformin greater than or equal to 1000 mg/day for at least 2 weeks
boolean
C0025598 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
Antidiabetics Oral Quantity
Item
currently at least one of other oad(s) reaching at least one-half of the recommended maximum dose for at least 2 weeks
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Glucohemoglobin measurement
Item
glycosylated haemoglobin (hba1c) between 7.5-11.0%
boolean
C0202054 (UMLS CUI [1])
Body mass index
Item
body mass index (bmi) between 18.5 - 35.0 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Glucose monitoring system Continuous | Blood Glucose Self-Monitoring
Item
be able and willing to perform continuous glucose monitoring system (cgms ) and self-monitored blood glucose (smbg)
boolean
C3873850 (UMLS CUI [1,1])
C0549178 (UMLS CUI [1,2])
C0005803 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Hypersensitivity Investigational New Drugs | Hypersensitivity Suspected Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Related | Hypersensitivity Suspected Pharmaceutical Preparations Related
Item
known or suspected allergy to trial product(s) or related products
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0013230 (UMLS CUI [2,3])
C0020517 (UMLS CUI [3,1])
C0013227 (UMLS CUI [3,2])
C0439849 (UMLS CUI [3,3])
C0020517 (UMLS CUI [4,1])
C0750491 (UMLS CUI [4,2])
C0013227 (UMLS CUI [4,3])
C0439849 (UMLS CUI [4,4])
Medical contraindication Metformin
Item
any contraindication of metformin
boolean
C1301624 (UMLS CUI [1,1])
C0025598 (UMLS CUI [1,2])
Investigational New Drugs
Item
receipt of investigational drug within the last 3 months prior to this trial
boolean
C0013230 (UMLS CUI [1])
Insulin regime chronic
Item
any history of chronic insulin therapy (more than 1 week of daily use)
boolean
C0557978 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
Systemic therapy Thiazolidinediones
Item
systemically treated with thiazolidinediones (tzds) for more than one month within 6 months prior to this trial
boolean
C1515119 (UMLS CUI [1,1])
C1257987 (UMLS CUI [1,2])
Pregnancy | Breast Feeding | Contraceptive methods Unwilling
Item
pregnancy, nursing mother, or unwillingness to use adequate contraception
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [3,1])
C0558080 (UMLS CUI [3,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial